Brandinium

Trademark search for:

TEGIMUN

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2007-05-23 — Application filed
  • 2007-05-30 — Application filed
  • 2007-09-04 — Final disposition recorded
  • 2007-09-04 — Assigned to examiner
  • 2007-09-05 — Final disposition recorded
  • 2008-01-28 — Teas/email correspondence entered
  • 2008-01-28 — Office action issued
  • 2008-01-28 — Correspondence received in law office
  • 2008-01-29 — Suspension letter written
  • 2008-01-30 — Letter of suspension mailed
  • 2008-07-30 — Suspension inquiry written
  • 2008-07-30 — Inquiry as to suspension mailed
  • 2008-07-30 — Assigned to lie
  • 2008-07-30 — Suspension checked - to attorney for action
  • 2008-09-11 — Paper received
  • 2008-09-16 — Amendment from applicant entered
  • 2008-09-16 — Correspondence received in law office
  • 2008-09-17 — Suspension letter written
  • 2008-09-18 — Letter of suspension mailed
  • 2009-03-18 — Suspension inquiry written
  • 2009-03-19 — Inquiry as to suspension mailed
  • 2009-08-05 — Teas response to suspension inquiry received
  • 2009-08-06 — Teas/email correspondence entered
  • 2009-08-06 — Correspondence received in law office
  • 2009-08-07 — Suspension letter written
  • 2009-08-07 — Letter of suspension mailed
  • 2009-09-17 — Teas response to suspension inquiry received
  • 2009-09-17 — Teas/email correspondence entered
  • 2009-09-17 — Correspondence received in law office
  • 2009-10-02 — Approved for pub - principal register
  • 2009-10-03 — Law office publication review completed
  • 2009-10-21 — Notice of publication
  • 2009-11-10 — Published for opposition
  • 2010-01-26 — Registered-principal register
  • 2016-09-02 — Cancelled sec. 8 (6-yr)
  • 2016-09-02 — Final status recorded

Owner Information

ANTISENSE Pharma GmbH
Regensburg DE
ANTISENSE Pharma GmbH
Regensburg DE
ANTISENSE Pharma GmbH
Regensburg DE

Correspondent

LAWRENCE E. ABELMAN ABELMAN, FRAYNE & SCHWAB
666 THIRD AVENUE
NEW YORK, NY 10017-5621
UNITED STATES

Filing Details

Filing Date:
2007-05-23
Status Date:
2016-09-02
Category:
Pharmaceuticals
Filing Year:
2007

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.